In 2019, there was a lot of consolidation in the veterinary diagnostic space, and 2020 promises more of the same. We know change is never easy so we wanted to share more details around our technology, the advantages it offers and our commitment to providing you consistent results and support in 2020 and beyond. We also wanted to provide a brief recap of the information we shared at VMX with both our clients and those who use other methods of allergy management.
Comfort Therapies:
Apoquel and Cytopoint are great tools. They do an excellent job of controlling symptoms. Nextmune was surprised at how many veterinarians at VMX had reported less than published success rates within their clinics. Many clinics also reported still using mostly Apoquel rather than migrating over to its newer counterpart, Cytopoint.
Veterinarians in general practice reported to us that the messaging they use most often for clients on comfort therapies informs the pet parent that the disease of allergy continues to progress, often until the therapies no longer work at all. Veterinarians also agreed that when they advise pet parents that the quality of life that can be achieved when doing the testing and starting treatment today is better than it will be than 6 months or a year from now, that resonated with pet parents. That approach, combined with our new Test & Treat package, has allowed our veterinary clients to migrate many of their allergy patients over from “comfort” therapies to real allergy relief.
Synthetic Reagents:
Unlike other allergy diagnostic labs, Nextmune does not report borderlines or borderline positives on our results. Therefore, we wanted to take some time to how we are able to reduce the “interference-based” reactions also known as borderline results and clarify why our testing does not have any borderline results.
Nextmune is consistently honing-in our testing methodologies to make the test more replicable and reliable. Our 30 years of refinement has generated the following benefits:
Along with all of these additional measures Nextmune is excited to be putting the finishing touches on another state-of-the-art testing technology that will be the first of its kind to be implemented here in the US. This, in addition to our existing testing process, will improve overall test results, specifically reliability and test accuracy and will be launching very soon and at no additional charge. We can’t wait for you to experience the added benefits the Spot Platinum+ will provide to your clinic, patients, and pet parents.